Treatment of Stimulant Addiction

Treatment of stimulant addiction concerns the management of cocaine and amphetamine-type stimulant use disorders. Unlike opioid and alcohol use disorders, stimulant use disorders have no medication of established efficacy, so psychosocial interventions, particularly contingency management, remain the mainstay of care.

Definition

Treatment of stimulant addiction is the management of cocaine and amphetamine-type stimulant use disorders, currently relying on psychosocial interventions because no medication has demonstrated reliable efficacy.

Scope

This topic covers why stimulant use disorders are pharmacologically challenging, the largely negative trials of candidate medications, and the central role of psychosocial treatment. It is a reference entry within addiction pharmacotherapy and does not provide prescribing or dosing guidance.

Core questions

• Why has no medication achieved established efficacy for stimulant use disorders?
• What does the trial evidence show for candidate agents such as dopamine agonists?
• Which psychosocial interventions have the best evidence for stimulant use disorders?
• How does stimulant pharmacology differ from opioid and alcohol systems in ways that complicate treatment?

Key concepts

• Stimulant use disorder
• Cocaine use disorder
• Methamphetamine use disorder
• Absence of approved pharmacotherapy
• Contingency management
• Dopaminergic reward system
• Off-label candidate agents

Mechanisms

Cocaine and amphetamines act on the dopamine, noradrenaline, and serotonin transporters, producing a strong surge of synaptic dopamine that drives their reinforcing effect. Efforts to develop pharmacotherapy have targeted this dopaminergic system with agents such as dopamine agonists, antidepressants, anticonvulsants, and stimulant substitutes, but trials have not yielded a medication with consistent efficacy. The Cochrane review by Minozzi and colleagues found dopamine agonists ineffective for cocaine dependence, and the meta-analysis by Chan and colleagues found no clearly effective pharmacotherapy for methamphetamine or amphetamine use disorder. Because medication has not succeeded, psychosocial approaches that directly reshape reinforcement, especially contingency management, carry the strongest evidence, as summarized by Dutra and colleagues.

Clinical relevance

Stimulant use disorders remain without an approved medication, so recognizing the strength of psychosocial treatment is important for interpreting the field; this is one of the clearest examples of a substance use disorder where pharmacotherapy has not yet succeeded. This entry is educational and descriptive and does not recommend specific treatments for individuals.

Epidemiology

Cocaine and amphetamine-type stimulants are among the most widely used illicit drugs globally, and stimulant-related harms have risen in several regions. The lack of effective pharmacotherapy makes the treatment gap for these disorders particularly consequential.

Evidence & guidelines

Systematic reviews and meta-analyses have not identified a medication with established efficacy for cocaine or methamphetamine use disorder, and guidelines therefore emphasize psychosocial interventions such as contingency management and cognitive-behavioural therapy. DSM-5 provides the diagnostic framework for stimulant use disorder.

History

Since the cocaine and methamphetamine epidemics of the late twentieth century, many medications have been tested for stimulant use disorders, including dopamine agonists, antidepressants, and anticonvulsants, but successive trials and reviews have been largely negative. This sustained lack of an effective medication has kept psychosocial treatments, and contingency management in particular, at the centre of care.

Debates

Is an effective pharmacotherapy for stimulant use disorder achievable?

Decades of trials targeting the dopaminergic system have not produced a reliably effective medication, leaving open whether agonist-substitution or other strategies can succeed, while contingency management remains the best-supported intervention.

Key figures

• Brian Chan
• Silvia Minozzi
• Lissa Dutra
• Nora Volkow

Seminal works

• chan-2019
• minozzi-2015

Frequently asked questions

Is there a medication for cocaine or methamphetamine addiction?

No medication has established efficacy for cocaine or methamphetamine use disorder; systematic reviews of candidate agents have been largely negative, so psychosocial treatment, especially contingency management, remains the mainstay.

Why is stimulant addiction harder to treat with medication than opioid addiction?

Opioid use disorder can be treated by acting directly on the mu-opioid receptor with agonists or antagonists, whereas the dopaminergic reward mechanisms driving stimulant use have not yielded a comparable, reliably effective pharmacological target.